• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同表型的克罗恩病储袋患者储袋失败的危险因素。

Risk factors for pouch failure in patients with different phenotypes of Crohn's disease of the pouch.

作者信息

Shen Bo, Remzi Feza H, Brzezinski Aaron, Lopez Rocio, Bennett Ana E, Lavery Ian C, Queener Elaine, Fazio Victor W

机构信息

Pouchitis Clinic, Digestive Disease Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA.

出版信息

Inflamm Bowel Dis. 2008 Jul;14(7):942-8. doi: 10.1002/ibd.20409.

DOI:10.1002/ibd.20409
PMID:18300279
Abstract

BACKGROUND

Crohn's disease (CD) of the pouch is one of the leading causes of pouch failure in patients with restorative proctocolectomy. Risk factors for pouch failure in these patients are yet to be identified. The aim of the study was to assess risk factors associated with pouch failure in patients with CD of the pouch.

METHODS

All patients with a confirmed diagnosis of CD of the pouch in the Pouchitis Clinic between 2002 and 2007 were evaluated. Patients with familial adenomatous polyposis, normal pouches, pouchitis, cuffitis, surgical complications, and other diseased pouch conditions were excluded. Pouch failure was defined as the requirement for a permanent diversion or pouch resection. Demographic and clinical factors were studied with univariable and multivariable analyses.

RESULTS

A total of 137 patients with CD of the pouch were included. Twenty-two patients (16%) developed pouch failure a median of 6 years after ileostomy takedown. Four of 50 patients (8.0%) with inflammatory CD, 4 of 30 (13.3%) with fibrostenotic CD, and 14 of 57 (24.6%) with fistulizing CD had pouch failure. A Kaplan-Meier plot for time to pouch failure by CD phenotype showed a trend toward association (P = 0.054) in patients with fistulizing CD. Adjusting for age, smoking status, and the use of immunomodulators or biologics, fistulizing CD was not found to be significantly associated with a higher hazard for pouch failure. Younger age, being an ex-smoker, and the use of immunomodulators or biologics were found to increase the hazard of pouch failure.

CONCLUSIONS

Younger age, being an ex-smoker, and the requirement for immunomodulators or biologics were associated with pouch failure. The identification of these risk factors may help delineate the natural history of CD of the pouch and shed light on proper clinical management and prognosis.

摘要

背景

储袋克罗恩病(CD)是行结直肠切除储袋肛管吻合术患者储袋功能衰竭的主要原因之一。这些患者储袋功能衰竭的危险因素尚未明确。本研究旨在评估储袋型CD患者储袋功能衰竭的相关危险因素。

方法

对2002年至2007年间储袋炎门诊确诊为储袋型CD的所有患者进行评估。排除患有家族性腺瘤性息肉病、储袋正常、储袋炎、袖口炎、手术并发症及其他储袋病变情况的患者。储袋功能衰竭定义为需要永久性造口转流或切除储袋。采用单因素和多因素分析研究人口统计学和临床因素。

结果

共纳入137例储袋型CD患者。22例患者(16%)在回肠造口关闭术后中位6年出现储袋功能衰竭。50例炎症型CD患者中有4例(8.0%)、30例纤维狭窄型CD患者中有4例(13.3%)、57例瘘管型CD患者中有14例(24.6%)出现储袋功能衰竭。按CD表型绘制的储袋功能衰竭时间的Kaplan-Meier曲线显示,瘘管型CD患者存在关联趋势(P = 0.054)。校正年龄、吸烟状态以及免疫调节剂或生物制剂的使用情况后,未发现瘘管型CD与储袋功能衰竭风险升高存在显著关联。发现年龄较小、既往吸烟以及使用免疫调节剂或生物制剂会增加储袋功能衰竭风险。

结论

年龄较小、既往吸烟以及需要使用免疫调节剂或生物制剂与储袋功能衰竭相关。识别这些危险因素可能有助于描绘储袋型CD的自然病程,并为恰当的临床管理和预后提供线索。

相似文献

1
Risk factors for pouch failure in patients with different phenotypes of Crohn's disease of the pouch.不同表型的克罗恩病储袋患者储袋失败的危险因素。
Inflamm Bowel Dis. 2008 Jul;14(7):942-8. doi: 10.1002/ibd.20409.
2
Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch.回肠储袋克罗恩病临床表型的风险因素。
Am J Gastroenterol. 2006 Dec;101(12):2760-8. doi: 10.1111/j.1572-0241.2006.00838.x.
3
Excessive weight gain is associated with an increased risk for pouch failure in patients with restorative proctocolectomy.体重过度增加与直肠结肠切除术后恢复患者的袋失败风险增加有关。
Inflamm Bowel Dis. 2013 Sep;19(10):2173-81. doi: 10.1097/MIB.0b013e31829bfc26.
4
Do clinical characteristics of de novo pouch Crohn's disease after restorative proctocolectomy affect ileal pouch retention?经直肠结肠切除术后新发袋状克罗恩病的临床特征是否影响回肠袋保留?
Dis Colon Rectum. 2014 Jan;57(1):76-82. doi: 10.1097/01.dcr.0000437691.52109.f2.
5
Clinical course of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomoses.溃疡性结肠炎患者行直肠结肠切除术和回肠储袋肛管吻合术后袖口炎的临床病程。
Inflamm Bowel Dis. 2013 Feb;19(2):404-10. doi: 10.1097/MIB.0b013e31828100ed.
6
External validation of a prognostic model of preoperative risk factors for failure of restorative proctocolectomy.术前风险因素预测保肛性直肠结肠切除术失败的预后模型的外部验证。
Colorectal Dis. 2017 Feb;19(2):181-187. doi: 10.1111/codi.13414.
7
Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.针对糖蛋白 2 的抗体是回肠贮袋患者肠道炎症的新型标志物。
J Crohns Colitis. 2013 Dec;7(11):e522-32. doi: 10.1016/j.crohns.2013.03.009. Epub 2013 Apr 30.
8
Endoscopic features associated with ileal pouch failure.与回肠贮袋失败相关的内镜特征。
Inflamm Bowel Dis. 2013 May;19(6):1202-9. doi: 10.1097/MIB.0b013e318280e77c.
9
IPAA-related sepsis significantly increases morbidity of ileoanal pouch excision.回肠肛管吻合术相关的脓毒症显著增加回肠储袋肛管切除术的发病率。
Dis Colon Rectum. 2015 May;58(5):488-93. doi: 10.1097/DCR.0000000000000330.
10
Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis.溃疡性结肠炎行结直肠切除回肠储袋肛管吻合术后回肠储袋肛管吻合口疾病的危险因素。
Clin Gastroenterol Hepatol. 2006 Jan;4(1):81-9; quiz 2-3. doi: 10.1016/j.cgh.2005.10.004.

引用本文的文献

1
Ubiquitous Colonic Ileal Metaplasia Consistent with the Diagnosis of Crohn's Colitis among Indeterminate Colitis Cohorts.在不确定性结肠炎队列中,普遍存在的结肠回肠化生符合克罗恩结肠炎的诊断。
Med Res Arch. 2023 Aug;11(8). doi: 10.18103/mra.v11i8.4188. Epub 2023 Jul 27.
2
The MYTHS of Crohn's Disease After Restorative Proctocolectomy with Ileal Pouch-anal Anastomosis for Ulcerative Colitis.溃疡性结肠炎行回肠储袋肛管吻合术式的全直肠系膜切除术后克罗恩病的误区
Jpn J Gastroenterol Hepatol. 2020;3(2). Epub 2020 Mar 11.
3
The Multifactorial Etiopathogeneses Interplay of Inflammatory Bowel Disease: An Overview.
炎症性肠病的多因素病因发病机制相互作用:概述
Gastrointest Disord (Basel). 2019 Mar;1(1):75-105. doi: 10.3390/gidisord1010007. Epub 2018 Oct 18.
4
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment.炎症性肠病中的袋炎:诊断、预后及治疗综述
Intest Res. 2021 Jan;19(1):1-11. doi: 10.5217/ir.2020.00047. Epub 2020 Nov 5.
5
Meta-analysis of the association of extraintestinal manifestations with the development of pouchitis in patients with ulcerative colitis.Meta 分析炎症性肠病患者肠外表现与贮袋炎发生的相关性。
BJS Open. 2019 Mar 13;3(4):436-444. doi: 10.1002/bjs5.50149. eCollection 2019 Aug.
6
47 Integrin Antagonist Vedolizumab for the Treatment of Refractory Ileitis.47. 整合素拮抗剂维多珠单抗治疗难治性回肠炎。
Case Rep Gastrointest Med. 2019 Apr 22;2019:2091089. doi: 10.1155/2019/2091089. eCollection 2019.
7
Serological, genetic and clinical associations with increased health-care resource utilization in inflammatory bowel disease.炎症性肠病患者的血清学、遗传学和临床特征与医疗资源利用增加的相关性。
J Dig Dis. 2018 Jan;19(1):15-23. doi: 10.1111/1751-2980.12566.
8
When Not to Pouch: Important Considerations for Patient Selection for Ileal Pouch-Anal Anastomosis.何时不宜进行回肠储袋肛管吻合术:回肠储袋肛管吻合术患者选择的重要考量因素
Gastroenterol Hepatol (N Y). 2017 Aug;13(8):466-475.
9
Human alpha defensin 5 is a candidate biomarker to delineate inflammatory bowel disease.人α-防御素5是一种用于鉴别炎症性肠病的候选生物标志物。
PLoS One. 2017 Aug 17;12(8):e0179710. doi: 10.1371/journal.pone.0179710. eCollection 2017.
10
The Failed J Pouch.失败的回肠储袋
Clin Colon Rectal Surg. 2016 Jun;29(2):123-9. doi: 10.1055/s-0036-1580724.